69 related articles for article (PubMed ID: 19074874)
1. Altered detoxification status and increased resistance to oxidative stress by K-ras transformation.
Recktenwald CV; Kellner R; Lichtenfels R; Seliger B
Cancer Res; 2008 Dec; 68(24):10086-93. PubMed ID: 19074874
[TBL] [Abstract][Full Text] [Related]
2. Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: a PET imaging and metabolomics-mass-spectrometry study.
Gaglio D; Valtorta S; Ripamonti M; Bonanomi M; Damiani C; Todde S; Negri AS; Sanvito F; Mastroianni F; Di Campli A; Turacchio G; Di Grigoli G; Belloli S; Luini A; Gilardi MC; Colangelo AM; Alberghina L; Moresco RM
Oncotarget; 2016 Aug; 7(32):52017-52031. PubMed ID: 27409831
[TBL] [Abstract][Full Text] [Related]
3. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein.
Kamphorst JJ; Nofal M; Commisso C; Hackett SR; Lu W; Grabocka E; Vander Heiden MG; Miller G; Drebin JA; Bar-Sagi D; Thompson CB; Rabinowitz JD
Cancer Res; 2015 Feb; 75(3):544-53. PubMed ID: 25644265
[TBL] [Abstract][Full Text] [Related]
4. Base excision repair accessory factors in senescence avoidance and resistance to treatments.
Vickridge E; Faraco CCF; Nepveu A
Cancer Drug Resist; 2022; 5(3):703-720. PubMed ID: 36176767
[TBL] [Abstract][Full Text] [Related]
5. Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells.
Subbarayan K; Massa C; Leisz S; Steven A; Bethmann D; Biehl K; Wickenhauser C; Seliger B
Oncoimmunology; 2022; 11(1):2069214. PubMed ID: 35529675
[TBL] [Abstract][Full Text] [Related]
6. New insights into the genetic contribution of ALDH2 rs671 in pancreatic carcinogenesis: Evaluation by mediation analysis.
Koyanagi YN; Oze I; Kasugai Y; Kawakatsu Y; Taniyama Y; Hara K; Shimizu Y; Imoto I; Ito H; Matsuo K
Cancer Sci; 2022 Apr; 113(4):1441-1450. PubMed ID: 35102643
[TBL] [Abstract][Full Text] [Related]
7. Lipid Metabolism Regulates Oxidative Stress and Ferroptosis in RAS-Driven Cancers: A Perspective on Cancer Progression and Therapy.
Bartolacci C; Andreani C; El-Gammal Y; Scaglioni PP
Front Mol Biosci; 2021; 8():706650. PubMed ID: 34485382
[No Abstract] [Full Text] [Related]
8. Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma.
Tuerhong A; Xu J; Shi S; Tan Z; Meng Q; Hua J; Liu J; Zhang B; Wang W; Yu X; Liang C
Cell Mol Life Sci; 2021 Jul; 78(14):5505-5526. PubMed ID: 34131808
[TBL] [Abstract][Full Text] [Related]
9. The impact of oncogenic RAS on redox balance and implications for cancer development.
Lim JKM; Leprivier G
Cell Death Dis; 2019 Dec; 10(12):955. PubMed ID: 31852884
[TBL] [Abstract][Full Text] [Related]
10. Glucose Metabolism in Pancreatic Cancer.
Yan L; Raj P; Yao W; Ying H
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31569510
[TBL] [Abstract][Full Text] [Related]
11. Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy.
Friedrich M; Jasinski-Bergner S; Lazaridou MF; Subbarayan K; Massa C; Tretbar S; Mueller A; Handke D; Biehl K; Bukur J; Donia M; Mandelboim O; Seliger B
Cancer Immunol Immunother; 2019 Oct; 68(10):1689-1700. PubMed ID: 31375885
[TBL] [Abstract][Full Text] [Related]
12. Linking CREB function with altered metabolism in murine fibroblast-based model cell lines.
Steven A; Leisz S; Wickenhauser C; Schulz K; Mougiakakos D; Kiessling R; Denkert C; Seliger B
Oncotarget; 2017 Nov; 8(57):97439-97463. PubMed ID: 29228623
[TBL] [Abstract][Full Text] [Related]
13. Regulation of S-formylglutathione hydrolase by the anti-aging gene klotho.
Xu Y; Sun Z
Oncotarget; 2017 Oct; 8(51):88259-88275. PubMed ID: 29179433
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity, Oxidative Stress, Cell Cycle Arrest, and Mitochondrial Apoptosis after Combined Treatment of Hepatocarcinoma Cells with Maleic Anhydride Derivatives and Quercetin.
Carrasco-Torres G; Baltiérrez-Hoyos R; Andrade-Jorge E; Villa-Treviño S; Trujillo-Ferrara JG; Vásquez-Garzón VR
Oxid Med Cell Longev; 2017; 2017():2734976. PubMed ID: 29163752
[TBL] [Abstract][Full Text] [Related]
15. Computational Model Predicts the Effects of Targeting Cellular Metabolism in Pancreatic Cancer.
Roy M; Finley SD
Front Physiol; 2017; 8():217. PubMed ID: 28446878
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and the unfulfilled promises of antioxidant agents.
Giorgio M
Ecancermedicalscience; 2015; 9():556. PubMed ID: 26284120
[TBL] [Abstract][Full Text] [Related]
17. TSPO interacts with VDAC1 and triggers a ROS-mediated inhibition of mitochondrial quality control.
Gatliff J; East D; Crosby J; Abeti R; Harvey R; Craigen W; Parker P; Campanella M
Autophagy; 2014; 10(12):2279-96. PubMed ID: 25470454
[TBL] [Abstract][Full Text] [Related]
18. The return of metabolism: biochemistry and physiology of the pentose phosphate pathway.
Stincone A; Prigione A; Cramer T; Wamelink MM; Campbell K; Cheung E; Olin-Sandoval V; Grüning NM; Krüger A; Tauqeer Alam M; Keller MA; Breitenbach M; Brindle KM; Rabinowitz JD; Ralser M
Biol Rev Camb Philos Soc; 2015 Aug; 90(3):927-63. PubMed ID: 25243985
[TBL] [Abstract][Full Text] [Related]
19. Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells.
Brunelli L; Caiola E; Marabese M; Broggini M; Pastorelli R
Oncotarget; 2014 Jul; 5(13):4722-31. PubMed ID: 24952473
[TBL] [Abstract][Full Text] [Related]
20. Molecular profiling of single Sca-1+/CD34+,- cells--the putative murine lung stem cells.
Hittinger M; Czyz ZT; Huesemann Y; Maneck M; Botteron C; Kaeufl S; Klein CA; Polzer B
PLoS One; 2013; 8(12):e83917. PubMed ID: 24391845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
